Unlock instant, AI-driven research and patent intelligence for your innovation.

Process for converting 9-dihydro-13-acetylbaccatin iii into docetaxel or paclitaxel

A C1-C12, C6-C12 technology, applied in the field of preparing anticancer drugs docetaxel or paclitaxel, can solve the problems of limited biomass resources, low separation yield and the like

Inactive Publication Date: 2010-09-15
6570763 CANADA
View PDF0 Cites 2 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

However, the supply of 10-deacetylbaccatin III is limited to date due to limited biomass resources and low isolation yields (50-165 mg / kg taxus baccata needles). To

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Process for converting 9-dihydro-13-acetylbaccatin iii into docetaxel or paclitaxel
  • Process for converting 9-dihydro-13-acetylbaccatin iii into docetaxel or paclitaxel
  • Process for converting 9-dihydro-13-acetylbaccatin iii into docetaxel or paclitaxel

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

Embodiment 2

Embodiment 3

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

Processes for the preparation of docetaxel and paclitaxel or analogs from 9-dihydro-13-acetylbaccatin III via key intermediates (4), (5), (6), (6'), (8) and (8') or via intermediate (12) as well as processes for the preparation of said intermediates are disclosed. Said processes involve, in particular, oxidation of the hydroxy group at C-10, reaction with side chain precursors and intramolecular isomerisation of the oxo at C-10 to produce the 9-oxo isomer. Paclitaxel and docetaxel are useful in the treatment of cancer. Formulae (I), (II), (III).

Description

field of invention The invention relates to a method for preparing anticancer drug docetaxel or paclitaxel. More specifically, the present invention relates to a method for the synthesis of docetaxel or paclitaxel from 9-dihydro-13-acetylbaccatin III, wherein 9-dihydro-13-acetylbaccatin III is isolated from Taxane compounds of the Canadian yew (Taxus canadensis), an evergreen shrub that grows in eastern Canada and the northeastern United States. Background technique Taxanes are substances that occur naturally in yew trees such as the Canadian yew common in eastern Canada and the northeastern United States. 9-dihydro-13-acetylbaccatin III is one of the chemicals extracted from the needles of Taxus chinensis, and is used especially to produce 10-deacetylbaccatin III, which is used for the preparation of paclitaxel and its analogs useful intermediates. The taxane family of terpenes is considered an extremely promising group of cancer chemotherapeutic agents. Many taxane de...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D305/14C07D413/12
CPCC07D305/14C07D413/12A61P35/00
Inventor 刘健
Owner 6570763 CANADA